
Pharmacally
35PHARMA
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in 35PHARMA
Mergers & AcquisitionsGSK’s Bold Lungstrike: Acquiring 35Pharma to Unleash HS235 on PHGSK completes its $950 million acquisition of 35Pharma, securing HS235, a next-generation activin pathway inhibitor with potential to address key safety gaps in pulmonary hypertension treatment.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.